Bone marrow biopsy at the end of induction to confirm complete responses in the GALLIUM trial. The number of evaluable patients is shown according to BMB result and radiologic response. (A) Postinduction BMB to confirm CMR according to PET. (B) Postinduction BMB to confirm CR according to CT. *Only patients with a CR by CT had a repeat biopsy. †Positive BMB, n = 613 (51.0%); indeterminate BMB, n = 20 (1.7%); data missing, n = 12 (1.0%).